Immediate Impact

1 from Science/Nature 68 standout
Sub-graph 1 of 20

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
4 intermediate papers

Works of W. Schroeder being referenced

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
2010
Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer
2002
and 1 more

Author Peers

Author Last Decade Papers Cites
W. Schroeder 459 281 201 17 632
Malkasian Gd 463 202 220 32 687
Elly Brockbank 404 187 325 22 671
Birgit Volgger 359 204 126 17 620
Maurie Markman 492 350 178 27 668
Decker Dg 370 151 187 22 590
Ryuichiro Tsunematsu 273 220 303 26 621
Patricia Rose 306 151 360 16 693
Catherine N. Correa 313 146 123 17 688
Karishma Mehra 406 127 185 12 648
Richard E. Hunter 408 127 384 26 687

All Works

Loading papers...

Rankless by CCL
2026